By Silent • September 12, 2026
The FDA is spending an afternoon on the future of psychedelic medicine — the harder question, what to do with what you saw, isn't on the agenda.
By Silent • February 8, 2026
Understand the limits of consent in altered states. Ensure emotional safety in your coaching practice. Contact us for guidance.
By Silent • February 4, 2026
Learn how insurance shapes psychedelic medicine standards. Understand accountability, documentation, & liability in coaching practices.
By Silent • January 21, 2026
Examine how commercialization affects ethical care in psychedelics. Understand the impact on trust & patient integration.
By Silent • January 20, 2026
Understand psychedelics as a collective responsibility in healing. Emphasize systemic support for integration and transformation.
By Silent • January 19, 2026
Examine the hidden dangers of premature scaling in psychedelics. Understand its impact on healing ðhical practices. Read more.
By Silent • January 16, 2026
The training gap in spiritual care threatens client safety. Understand its impact & advocate for better practitioner competence.
By Silent • January 14, 2026
Examine the ethical risks of psychedelic access in coaching. Understand informed consent & the dangers of resource extraction.
By Silent • January 13, 2026
Explore the importance of integration in psychedelic healing. Ensure safe practices with trained facilitators. Contact us for guidance.
By Silent • January 12, 2026
Understand the key challenges in healthcare insurance for 2026. Ensure ethical care with proper standards & protocols.